AAPL   324.55 (-0.18%)
MSFT   184.85 (-0.28%)
FB   230.16 (+0.00%)
GOOGL   1,431.67 (-0.53%)
AMZN   2,490.86 (+0.50%)
NVDA   349.86 (-0.26%)
BABA   217.10 (-0.69%)
MU   48.83 (-0.18%)
GE   7.33 (-0.41%)
TSLA   893.10 (+1.15%)
AMD   53.21 (+0.91%)
T   31.37 (-0.48%)
ACB   14.10 (-1.40%)
F   6.21 (+0.32%)
GILD   74.32 (-0.11%)
DIS   122.56 (+0.31%)
NFLX   426.40 (+1.05%)
BAC   25.78 (-0.81%)
BA   184.64 (+6.63%)
AAPL   324.55 (-0.18%)
MSFT   184.85 (-0.28%)
FB   230.16 (+0.00%)
GOOGL   1,431.67 (-0.53%)
AMZN   2,490.86 (+0.50%)
NVDA   349.86 (-0.26%)
BABA   217.10 (-0.69%)
MU   48.83 (-0.18%)
GE   7.33 (-0.41%)
TSLA   893.10 (+1.15%)
AMD   53.21 (+0.91%)
T   31.37 (-0.48%)
ACB   14.10 (-1.40%)
F   6.21 (+0.32%)
GILD   74.32 (-0.11%)
DIS   122.56 (+0.31%)
NFLX   426.40 (+1.05%)
BAC   25.78 (-0.81%)
BA   184.64 (+6.63%)
AAPL   324.55 (-0.18%)
MSFT   184.85 (-0.28%)
FB   230.16 (+0.00%)
GOOGL   1,431.67 (-0.53%)
AMZN   2,490.86 (+0.50%)
NVDA   349.86 (-0.26%)
BABA   217.10 (-0.69%)
MU   48.83 (-0.18%)
GE   7.33 (-0.41%)
TSLA   893.10 (+1.15%)
AMD   53.21 (+0.91%)
T   31.37 (-0.48%)
ACB   14.10 (-1.40%)
F   6.21 (+0.32%)
GILD   74.32 (-0.11%)
DIS   122.56 (+0.31%)
NFLX   426.40 (+1.05%)
BAC   25.78 (-0.81%)
BA   184.64 (+6.63%)
AAPL   324.55 (-0.18%)
MSFT   184.85 (-0.28%)
FB   230.16 (+0.00%)
GOOGL   1,431.67 (-0.53%)
AMZN   2,490.86 (+0.50%)
NVDA   349.86 (-0.26%)
BABA   217.10 (-0.69%)
MU   48.83 (-0.18%)
GE   7.33 (-0.41%)
TSLA   893.10 (+1.15%)
AMD   53.21 (+0.91%)
T   31.37 (-0.48%)
ACB   14.10 (-1.40%)
F   6.21 (+0.32%)
GILD   74.32 (-0.11%)
DIS   122.56 (+0.31%)
NFLX   426.40 (+1.05%)
BAC   25.78 (-0.81%)
BA   184.64 (+6.63%)
Log in

OTCMKTS:AVMXYAVITA MED LTD/S Stock Price, Forecast & News

$7.89
0.00 (0.00 %)
(As of 11/27/2019)
Add
Compare
Today's Range
$7.89
Now: $7.89
$7.89
50-Day Range
$7.89
MA: $7.89
$7.89
52-Week Range
$1.06
Now: $7.89
$8.58
VolumeN/A
Average Volume183,275 shs
Market Capitalization$651.87 million
P/E RatioN/A
Dividend YieldN/A
Beta1.28
Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products for the treatment of burns, chronic wounds, and aesthetics indications. The company's patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. Its lead product, RECELL System, is used in the treatment of various skin defects, such as burns and plastic reconstructive procedures. The company also offers ReGenerCell for chronic wounds and ReNovaCell for the restoration of pigmentation. Avita Medical Limited is based in Valencia, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.39 out of 5 stars


Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:AVMXY
CUSIPN/A
CIKN/A
Phone661-367-9170

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.51 million
Book Value$0.26 per share

Profitability

Miscellaneous

Employees55
Market Cap$651.87 million
Next Earnings DateN/A
OptionableNot Optionable

Receive AVMXY News and Ratings via Email

Sign-up to receive the latest news and ratings for AVMXY and its competitors with MarketBeat's FREE daily newsletter.

AVITA MED LTD/S (OTCMKTS:AVMXY) Frequently Asked Questions

How has AVITA MED LTD/S's stock been impacted by COVID-19 (Coronavirus)?

AVITA MED LTD/S's stock was trading at $7.89 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AVMXY shares have increased by 0.0% and is now trading at $7.89. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of AVITA MED LTD/S?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AVITA MED LTD/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for AVITA MED LTD/S.

What price target have analysts set for AVMXY?

1 equities research analysts have issued 12 month price objectives for AVITA MED LTD/S's shares. Their forecasts range from $10.00 to $10.00. On average, they anticipate AVITA MED LTD/S's stock price to reach $10.00 in the next year. This suggests a possible upside of 26.7% from the stock's current price. View analysts' price targets for AVITA MED LTD/S.

Has AVITA MED LTD/S been receiving favorable news coverage?

News coverage about AVMXY stock has been trending somewhat negative on Thursday, InfoTrie reports. The research group rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. AVITA MED LTD/S earned a media sentiment score of -1.9 on InfoTrie's scale. They also gave media stories about the medical device company a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an impact on the company's share price in the near future. View the latest news aboutAVITA MED LTD/S.

Who are some of AVITA MED LTD/S's key competitors?

Who are AVITA MED LTD/S's key executives?

AVITA MED LTD/S's management team includes the following people:
  • Dr. Michael S. Perry, CEO & Director (Age 60)
  • Mr. Timothy Rooney, Chief Admin. Officer & Interim CFO
  • Mr. Andrew Quick, Chief Technology Officer
  • Ms. Erin Liberto, Chief Commercial Officer
  • Mr. Adam Kelliher, Consultant

What is AVITA MED LTD/S's stock symbol?

AVITA MED LTD/S trades on the OTCMKTS under the ticker symbol "AVMXY."

How do I buy shares of AVITA MED LTD/S?

Shares of AVMXY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AVITA MED LTD/S's stock price today?

One share of AVMXY stock can currently be purchased for approximately $7.89.

How big of a company is AVITA MED LTD/S?

AVITA MED LTD/S has a market capitalization of $651.87 million and generates $5.51 million in revenue each year. The medical device company earns $-24,750,000.00 in net income (profit) each year or ($0.39) on an earnings per share basis. AVITA MED LTD/S employs 55 workers across the globe.

What is AVITA MED LTD/S's official website?

The official website for AVITA MED LTD/S is www.avitamedical.com.

How can I contact AVITA MED LTD/S?

AVITA MED LTD/S's mailing address is 28159 Avenue Stanford Suite 220, Valencia CA, 91355. The medical device company can be reached via phone at 661-367-9170 or via email at [email protected]

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.